These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17539007)

  • 1. Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome?
    Darwish Murad S; Kim WR; de Groen PC; Kamath PS; Malinchoc M; Valla DC; Janssen HL
    Liver Transpl; 2007 Jun; 13(6):867-74. PubMed ID: 17539007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model.
    Sun QF; Ding JG; Xu DZ; Chen YP; Hong L; Ye ZY; Zheng MH; Fu RQ; Wu JG; Du QW; Chen W; Wang XF; Sheng JF
    J Viral Hepat; 2009 Jul; 16(7):464-70. PubMed ID: 19413694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic indices for Budd-Chiari syndrome: valid for clinical studies but insufficient for individual management.
    Rautou PE; Moucari R; Escolano S; Cazals-Hatem D; Denié C; Chagneau-Derrode C; Charpignon C; Lédinghen Vd; Grenouillet-Delacre M; Habersetzer F; Nousbaum JB; Denninger MH; Valla DC; Plessier A
    Am J Gastroenterol; 2009 May; 104(5):1140-6. PubMed ID: 19337247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
    Huo TI; Lin HC; Huo SC; Lee PC; Wu JC; Lee FY; Hou MC; Lee SD
    Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era.
    Ripoll C; Bañares R; Rincón D; Catalina MV; Lo Iacono O; Salcedo M; Clemente G; Núñez O; Matilla A; Molinero LM
    Hepatology; 2005 Oct; 42(4):793-801. PubMed ID: 16175621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.
    Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; La Barba G; Zanello M; Grazi GL; Pinna AD
    Liver Transpl; 2006 Jun; 12(6):966-71. PubMed ID: 16598792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
    Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria.
    Dhiman RK; Jain S; Maheshwari U; Bhalla A; Sharma N; Ahluwalia J; Duseja A; Chawla Y
    Liver Transpl; 2007 Jun; 13(6):814-21. PubMed ID: 17370333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of short-term prognosis on patients with chronic severe hepatitis B using the model for end-stage liver disease].
    Zhou J; He WF; Tang XE
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):416-8. PubMed ID: 17631710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.
    Cai CJ; Chen HA; Lu MQ; Chen GH
    Chin Med J (Engl); 2008 Oct; 121(20):2065-9. PubMed ID: 19080277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of a covered vs. uncovered transjugular intrahepatic portosystemic shunt in Budd-Chiari syndrome.
    Darwish Murad S; Luong TK; Pattynama PM; Hansen BE; van Buuren HR; Janssen HL
    Liver Int; 2008 Feb; 28(2):249-56. PubMed ID: 18251982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical usefulness of DeltaMELD to predict the survival of patients with liver cirrhosis].
    Eun SH; Kim YS; Jang JY; Cheon YG; Kim YS; Cho YD; Lee JS; Lee MS; Kim JH; Shim CS; Kim BS
    Korean J Hepatol; 2006 Dec; 12(4):530-8. PubMed ID: 17237631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical value of Child-Turcotte-Pugh and model for end-stage liver disease score to predict the prognosis of chronic severe hepatitis].
    Jiang ZS; Jiang JN
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):412-5. PubMed ID: 17631709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis.
    Radha Krishna Y; Saraswat VA; Das K; Himanshu G; Yachha SK; Aggarwal R; Choudhuri G
    Liver Int; 2009 Mar; 29(3):392-8. PubMed ID: 19267864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment.
    Yu JW; Sun LJ; Zhao YH; Li SC
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1242-9. PubMed ID: 18637053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites.
    Yoo HY; Edwin D; Thuluvath PJ
    Am J Gastroenterol; 2003 Jun; 98(6):1395-9. PubMed ID: 12818287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of prognosis on patients with severe viral hepatitis using the model for end-stage liver disease].
    Wong ZH; Cai SQ
    Zhonghua Gan Zang Bing Za Zhi; 2005 Apr; 13(4):249-51. PubMed ID: 15850508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applicability of MELD as a short-term prognostic indicator in patients with chronic liver disease: an Indian experience.
    Mishra P; Desai N; Alexander J; Singh DP; Sawant P
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1232-5. PubMed ID: 17688663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.